Provider profile · Brand-name only

Hims & Hers

Evidence-sourced

Written and fact-checked to our published editorial standards.Last updated 2026-07-26. Every clinical claim on this page is sourced to a named primary authority, listed at the foot of the page — see how we research, source, and correct our work.

A consumer telehealth brand that exited compounded semaglutide for new patients following a settlement with Novo Nordisk, and now separates its recurring membership fee from a separate charge for whichever brand-name medication is prescribed.

This is not a review

We have not personally used Hims & Hers, so we are not rating quality of care, wait times, or customer service. What follows is Hims & Hers’s own published terms, checked against independent reporting where we found it. See our full methodology on the provider directory.

Notice

Hims & Hers previously offered compounded semaglutide and drew public criticism from Novo Nordisk over how it was marketed, before the March 2026 settlement ended that practice for new patients.

Source: Hims & Hers newsroom

At a glance

Access model: Brand-name only
Medications offered: Wegovy (pen and pill)Zepbound (KwikPen and vial)FoundayoOzempic (pill)
Prescriber: Licensed clinicians via telehealth evaluation
Insurance: Primarily cash-pay; membership does not guarantee a prescription
Membership / program fee: $39 first month, $149/month thereafter (clinical membership, billed separately from medication)
Cash-pay from: Medication from $149–$399/month depending on product and dose
States served: Not published in a single state-coverage list — confirm at signup

On compounding

Settled with Novo Nordisk on 9 March 2026 and exited compounded semaglutide for new patients; now prescribes FDA-approved brand-name products.

For the fuller regulatory picture — the pending FDA proposal on 503B compounding and what it does and doesn’t affect — see the explainer on the main directory page.

How to reach Hims & Hers

Visit Hims & Hers’s own site to confirm current pricing, state availability, and eligibility — all of the figures above can change without notice, and only the provider itself has the current version.

How this compares

Other providers with a similar access model or worth contrasting against:

Sources

Each source below supports specific statements on this page. We cite the strongest available authority and verify against the current version before publishing.

Hims & Hers — published termsHims & HersSupports: Access model, medications, prescriber type, insurance, pricing, and state coverage as stated in this profile.
Hims & Hers previously offered compounded semaglutide and dr…Hims & Hers newsroomSupports: The regulatory or litigation flag noted above.

This page is general education, not medical advice. Talk to your own healthcare provider about your situation before starting, stopping, or changing any medication.